Bluejay Diagnostics, Inc. (BJDX) Operating cash flow 2020–2025
Bluejay Diagnostics, Inc. (BJDX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$6.1MFY2025 · since FY2020: -$508,710 → -$6.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.1M | +22.6% |
| FY2024 | -$7.8M | +5.9% |
| FY2023 | -$8.3M | -7.4% |
| FY2022 | -$7.7M | -77.3% |
| FY2021 | -$4.4M | -758.4% |
| FY2020 | -$508,710 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BJDX financial trends
BJDX RevenueBJDX Net incomeBJDX Net marginBJDX Gross profitBJDX Gross marginBJDX Operating incomeBJDX Operating marginBJDX Free cash flowBJDX Capital expendituresBJDX Return on equityBJDX Stock buybacksBJDX Dividends paidBJDX Total assetsBJDX Total liabilitiesBJDX Shareholders’ equityBJDX overview →